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SUMMARY
Childhood rubella infection in early pregnancy can lead to fetal death or congenital rubella
syndrome (CRS) with multiple disabilities. Reduction of transmission via universal vaccination
can prevent CRS, but inadequate coverage may increase CRS numbers by increasing the average
age at infection. Consequently, many countries do not vaccinate against rubella. The World
Health Organization recommends that for safe rubella vaccination, at least 80% coverage of each
birth cohort should be sustained. The nonlinear relationship between CRS burden and infection
dynamics has been much studied; however, how the complex interaction between epidemic and
demographic dynamics aﬀects minimum safe levels of coverage has not been quantitatively
evaluated across scales necessary for a global assessment. We modelled 30-year CRS burdens
across epidemiological and demographic settings, including the eﬀect of local interruption of
transmission via stochastic fadeout. Necessary minimum vaccination coverage increases markedly
with birth and transmission rates, independent of amplitude of seasonal ﬂuctuations in
transmission. Susceptible build-up in older age groups following local stochastic extinction of
rubella increased CRS burden, indicating that spatial context is important. In low birth-rate
settings, 80% routine coverage is a conservative guideline, particularly if supplemented
with campaigns and vaccination of women of childbearing age. Where birth and transmission
rates are high, immunization coverage must be well above 80% and campaigns may be needed.
Policy-makers should be aware of the potential negative eﬀect of local extinction of rubella, since
heterogeneity in vaccination coverage will shape extinction patterns, potentially increasing CRS
burdens.
Key words: CRS, demography, extinction, rubella, seasonality, vaccine coverage.
* Author for correspondence : Dr C. J. E. Metcalf, Department of Zoology, Oxford University, Oxford, OX1 3PS, UK.
(Email : charlotte.metcalf@zoo.ox.ac.uk)
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons
Attribution-NonCommercial-ShareAlike licence<http://creativecommons.org/licenses/by-nc-sa/2.5/>. The written permission of
Cambridge University Press must be obtained for commercial re-use.
Epidemiol. Infect. (2012), 140, 2290–2301. f Cambridge University Press 2012
doi:10.1017/S0950268812000131
INTRODUCTION
Rubella is a directly transmitted childhood infection
that induces lifelong immunity. Infection in children is
rarely severe. However, maternal rubella infection
during the ﬁrst trimester of pregnancy can lead to
infection of the fetus, causing hearing impairment,
cataracts and congenital heart disease which form
the classical triad of congenital rubella syndrome
(CRS) [1]. Other manifestations can include micro-
cephaly, low birth weight, and mental retardation.
Consequently, those with CRS often require lifelong
care. Thus in high- and middle-income countries,
economic beneﬁts from elimination of CRS are esti-
mated to be high [2].
Rubella vaccine has been licensed for nearly 50
years, is highly eﬃcacious and available as combined
measles-rubella (MR) or measles-mumps-rubella
(MMR) vaccine. However, the challenge of prevent-
ing CRS by rubella-containing vaccine (RCV) is
complex, because feedbacks between incidence and
rate of infection mean that routine infant vaccination
(‘universal vaccination’) will tend to increase the av-
erage age of infection, although if vaccine coverage is
high enough, the age-speciﬁc incidence of rubella de-
creases at all ages [3]. Thus, an intervention that is
not implemented optimally may actually worsen the
situation.
Epidemiological models are useful tools for assess-
ing the risks and beneﬁts of immunization [4]. Because
of the complexity of serious disease risk as a function
of age and nonlinear epidemic dynamics, there is a
long history of modelling rubella vaccination, es-
pecially in high-income, low birth-rate contexts [5–8].
However, these analyses do not consider a range of
factors known to strongly impact nonlinear epidemic
dynamics. Speciﬁcally, we do not know how a wider
range of birth rates (which can strongly aﬀect
periodicity of immunizing infections [9]) will aﬀect
the relationship between infection and disease risk
in rubella. Further, the impact of seasonal forcing of
infection, spatial dynamics and demographic stoch-
asticity (all of which can be profound for infections
in general and rubella in particular [10, 11]) have not
been considered.
Current proposals to roll out rubella vaccination
globally require us to address these dynamical gaps,
and explore rubella infection and disease dynamics
across a range of contexts that are globally represen-
tative. Here, we explore minimum coverage re-
quired to prevent a CRS increase after introduction of
universal rubella vaccination, rooting our analysis in
the current public health context, and ranging over
the plausible extent of demographic contexts and re-
maining uncertainties in rubella transmission. The
results of this analysis are also more generally relevant
to any infection with a complex relationship between
infection and disease risk as a function of age.
To prevent CRS, two approaches have been used.
The ﬁrst aims to provide direct protection to women
before they reach childbearing age by selectively vac-
cinating girls and young women [5, 12]. This approach
has little eﬀect on population-wide rubella trans-
mission and has been recommended by WHO for
countries aiming to reduce CRS incidence only
[13, 14]. The second approach aims to reduce or
eliminate rubella transmission by universal vacci-
nation of male and female infants and young
children, sometimes combined with supplementary
catch-up campaigns in older age groups [3, 14].
Previous mathematical models indicate that if vacci-
nation of infants and young children is to be the sole
strategy, coverage of at least around 80% is required
[5, 7, 8] to avoid a potential increase in the burden of
CRS [5, 12, 15] and this is the recommendation of
WHO [3, 13, 14]. With suﬃcient immunization, con-
trol of rubella without increased CRS does appear to
be tractable: the region of the Americas has sustained
high infant RCV coverage and conducted mass cam-
paigns of adolescents and adults, and reported elim-
ination of endemic rubella transmission in 2010
[3]. However, it is not clear, that these targets can
be met in all countries : in 2009, WHO-UNICEF
estimates for global routine measles vaccine cover-
age of infants and young children were 82%, with
just 69% for the African region (http://apps.who.int/
immunization_monitoring/en/globalsummary/time
series/tswucoveragedtp3.htm; accessed 23 December
2010; note some countries in each region have at-
tained the goal). Mass measles campaigns, known as
supplementary immunization activities (SIAs), are
regularly conducted in high measles-mortality coun-
tries and many countries with elimination goals [16],
and will partly compensate for lower routine cover-
age. However, there are concerns that there is inad-
equate funding to support follow-up SIAs [16]. How
the presence and absence of these varied types of
measles immunization activities aﬀect the safe mini-
mum level of added rubella vaccination is a focus of
our investigation (note that while rubella elimination
may be a key long-term goal, this was not addressed
here).
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We focus our analyses on low-income countries,
where rubella vaccination is rare [3] but estimates of
CRS incidence (up to 246/100 000 live births in Africa
[17]) suggest high rewards of a successful vaccination
programme. Modelling has so far focused mainly on
high-income countries (e.g. [5, 8], although see [15]),
but several factors suggest that patterns may diﬀer in
low-income contexts [15]. First, higher birth rates will
entail a lower average age of infection in the absence
of vaccination. Second, rubella transmission intensity
may be greater (estimates of the basic reproduction
number, R0, or the number of secondary infectious
persons caused by a single infectious individual in
a completely susceptible population range from 6.9
to 11.8 in Addis Ababa, Ethiopia [18] compared
to 2.4–7.8 in Europe [6, 19]). This will decrease the
average age of infection and make it more diﬃcult to
interrupt transmission. Third, vaccination coverage
may be more heterogeneous in low-income countries
due to isolation of communities or inequitable access
to care (including access to private sector vaccination
[15]). Evidence suggests that rubella has a large criti-
cal community size or population size above which
stochastic extinction does not occur [20, 21], and this
may combine with spatially heterogeneous vacci-
nation uptake to allow build-up of susceptible in-
dividuals, altering CRS burdens in ways not yet
explored [22]. Fourth, seasonality in transmission is
little known for rubella (see [21, 22]), but is high
in some low-income countries for measles, another
directly transmitted airborne childhood infection.
Large seasonal ﬂuctuations in transmission can aﬀect
dynamics [23] and incidence over age [24], warranting
attention in the context of CRS. Relatively low-
amplitude seasonality might also matter, since rubella
is thought to have lower transmission than measles,
which might lead to multi-annual dynamics via an
interaction between seasonality and transient dy-
namics due to demographic stochasticity [11, 21].
Finally, the age pattern of transmission may diﬀer
from industrialized countries, particularly as trans-
mission in industrialized countries is shaped by school
terms [9], whereas school-attendance may be lower in
low-income countries.
We developed a strategic model to explore CRS
dynamics after introduction of vaccination across
globally representative scenarios, speciﬁcally asking:
(i) when is 80% vaccine coverage of infants and young
children suﬃcient to prevent increases in CRS inci-
dence, and how sensitive is this to R0, seasonality, and
birth rate? (ii) how is this 80% requirement altered by
the addition of typical measles control immunization
strategies [regular SIA (‘follow-up’) campaigns or a
starting (‘catch-up’) campaign], or vaccination of
women of childbearing age? and (iii) how will stoch-
astic dynamics aﬀect these conclusions, and what
spatial scenarios are of particular concern?
MATERIALS AND METHODS
We developed an age-structured model to quantify
the eﬀects of rubella vaccination in settings with dif-
ferent birth rates, basic reproduction numbers, and
magnitudes of seasonal variation in transmission.
The key element of the model is a matrix that at
every time-step deﬁnes transition from every possible
epidemiological stage (e.g. infected, susceptible, re-
covered) and age combination to every other epi-
demiological stage and age combination, following
methods developed previously [25–27]. The popu-
lation was stratiﬁed into 80 age groups (monthly
strata up to age 4 years ; yearly thereafter). We as-
sumed that mortality was constant over age (i.e. a
type II pattern, similar to that in many developing
countries ; altering this does not aﬀect our qualitative
results), and that the probability of survival at each
age was such that the population size was constant
over time (at 750 000, similar to that of Niamey,
Niger) given the chosen birth rate. Each age stratum
was subdivided into epidemiological groups [‘ma-
ternally immune’ M (relevant only for the ﬁrst few
age groups) ; ‘susceptible ’ S; ‘ infected’ I ; ‘recovered’
R; and ‘vaccinated’ V; taken to indicate successful
vaccination] [25]. The time-step of the model was set
to approximate the generation time for rubella [9] at
2 weeks, i.e. there are 24 infection generations per year
(see Supplementary Information S1, available online).
We assumed constant rates of movement between age
strata, i.e. for age stratum a, the rate of ageing into the
next age stratum is ua=1/[(length of age group a in
years)r24] ; u could also be set to capture a situation
of cohort ageing [15, 28], but given the absence of
evidence for term-time forcing in many contexts of
interest [23], we retained the simpler formulation.
Maternal immunity for rubella is estimated to last 3–9
months [5, 18] ; accordingly, we modelled the prob-
ability of remaining in the maternal immunity group
over age as an exponential decay function with a
constant rate of 0.95 per month (Fig. S1a). The mag-
nitude of R0 combined with the population size N sets
the intensity of transmission with R0=bN, where b
is average transmission. To explore seasonal forcing
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eﬀects, the intensity of transmission was varied over
the year by setting bt=b(1+a cos (2pt=24)) for each
time step t (Fig. S1b); a reﬂects the factor by which
the peak and lowest value of R0 diﬀer from the aver-
age, and t is divided by 24, as there are 24 discrete
time-steps in a year. We assumed here that seasonality
aﬀects all age groups in the same way. The probability
of becoming infected is deﬁned as
wa(n(t))=1x exp x
X
j
ba, j, tI
c
j, t
h i
, (1)
where ba,j,t is the rate of transmission between in-
dividuals in age groups a and j at time t, and c cap-
tures heterogeneities in mixing not directly modelled
[9, 29] and the eﬀects of discretization of the under-
lying continuous time process [30]. The probability
of becoming infected can be used for both determin-
istic and stochastic simulations (see Supplementary
Information S1 for details). Figure S2 illustrates
resulting deterministic dynamics, as well as sensi-
tivity to the chosen generation time. Supplementary
Information S2 and Figure S3 provide model vali-
dation. To realistically capture routine infant and
young child vaccination, we parameterized our model
to reﬂect access to measles vaccination in Zambia
(Fig. S1c) according to Lessler et al. [31]. Diﬀerent
levels of coverage were modelled by scaling this esti-
mated density of vaccination over age such that total
coverage achieved at age 3 years reﬂected the desired
levels of coverage. Through interference from ma-
ternal antibodies successful vaccination is less com-
mon in the very young, hence, we further multiplied
the probability of receiving vaccination by an age-
speciﬁc probability of vaccination success (Fig. S1d)
parameterized from Boulianne et al. [32] ; their results
indicate that vaccine eﬃcacy maximally attains 0.97.
We modelled vaccination of women of childbearing
age assuming that access to vaccination increased
gradually from age 15 years (Fig. S1e) and that
coverage attained was equivalent to half the coverage
attained in the routine infant and young children
vaccination part of the programme, scaling appropri-
ately, as above. There is little information from which
to parameterize this part of the model, as currently
routine vaccination of women, other than tetanus
toxoid vaccination of pregnant women, is rare in
low-income countries. For both types of vaccination,
continuous probability distribution functions were
converted to bi-weekly transition probabilities by the
appropriate integration. We modelled starting vacci-
nation campaigns and SIAs as campaigns lasting 2
weeks, and accessing a high proportion of the targeted
age range (90%), regardless of the degree of coverage
attained by routine vaccination, i.e. SIA vaccination
uptake being assumed to be independent of routine
vaccination uptake.
We set transmission to be constant over age. Since
there is evidence that the force of infection is lower
in adults than in children in both high- [33] and
low-income [24] contexts, the assumption that trans-
mission does not vary with age leads to an overesti-
mate in the average age of infection, and the burden
of CRS. Overall, given both paucity of information,
and issues of numerical tractability, the model
necessarily makes a number of assumptions. These
are addressed in detail in the Discussion.
Exploring diﬀerent vaccination strategies
We considered the outcome of diﬀerent immunization
strategies set to reﬂect current measles immunization
activities including (i) universal vaccination of infants
and young children only (a method that would rarely
be used alone, but serves as a baseline to be combined
with other strategies) ; (ii) universal vaccination of
infants and young children and regular SIAs (‘ follow-
up campaigns’) targeting all children aged between
1 and 4 at 4-year intervals, starting in the fourth year
after initiation of vaccination; (iii) universal vacci-
nation of infants and young children, regular SIAs
of 1- to 4-year-olds, and a starting (‘catch-up’) cam-
paign in the ﬁrst year of vaccination targeting 1- to
4-year-olds ; (iv) the same, but with the starting
campaign targeting 1- to 14-year-olds; and (v) the
same, but with additionally a campaign targeting
women of childbearing age. For the latter, we ex-
panded the model to incorporate both sexes to allow
for vaccination of women only (see Supplementary
Information S1). For all immunization strategies,
pre-vaccination equilibrium numbers of individuals
in each epidemiological and age stratum were ident-
iﬁed numerically, and the chosen immunization strat-
egy was implemented into a population deﬁned by this
structure.
To calculate the CRS burden, we used a pattern of
fertility over age to deﬁne the risk group, i.e. pregnant
women in the ﬁrst 16 weeks of pregnancy (Fig. S1f,
set to reﬂect fertility in Niger) and assumed that the
probability of CRS following infection during the
ﬁrst 16 weeks is c=0.65 [15]. Combining this value,
c, with the numerically estimated cumulative risk of
infection over the past 16 weeks, denoted Wt, with
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fertility in each age group, fa, we used our model
output to calculate the number of CRS cases expected
in the presence or absence of vaccination at each time-
step. Their ratio deﬁnes the risk ratio [5] ; values >1
indicate more cases in the presence than in the absence
of vaccination. The exact temporal pattern of the
risk ratio will depend on the balance of diﬀerent
key epidemiological drivers (demography, season-
ality, coverage). We assessed these eﬀects taking
yearly values of the risk ratio following the start of
vaccination, i.e.
ry=
P
t2y
P
a cWt faS
*
a, t
P
t2y
P
a cWt faSa, t
, (2)
where * indicates the situation where the population
has been vaccinated. We also tracked predicted CRS
incidence (Supplementary Information S1).
The range of demographic and epidemiological
contexts
We explored outcomes for birth rates ranging from
12/1000 per year (e.g. European countries, China) to
50/1000 per year (Niger, at the upper end of the scale ;
many African countries have lower birth rates) ;
and for R0=6 (the average reported for rubella in
Europe), R0=8 (at the high end of the scale reported
for Europe) and R0=12 (reﬂecting the high end of the
scale for estimates in Africa and Mexico [18, 21]). For
seasonality, we explored results across a range of a
from 0 (no seasonality) to 0.6 (high, as estimated in
Niger for measles [23]).
RESULTS
CRS burden in a deterministic setting
Changes through time of the relative CRS burden
For each vaccination strategy, we projected the
population forwards through time according to
demographic and epidemiological transitions, calcu-
lated the number of CRS cases expected with or
without vaccination, and took their yearly ratios for
diﬀerent coverage levels. For all immunization strat-
egies, ﬁrst, the relative burden of CRS decreases.
Then, if coverage is low and SIAs are not undertaken,
the relative burden can rise, potentially reaching
values>1 (Fig. 1a) ; i.e. more CRS cases occurring in
that particular year than would have in the absence
of vaccination. Implementing regular SIAs leads to
sporadic increases in the average age of infection (by
immunizing young individuals) leading to spikes in the
relative burden (Fig. 1b–d) ; but, overall, for equival-
ent routine coverage, implementing SIAs results in
fewer years where the relative burden is>1, via more
eﬀective control of the infection. Outcomes depend on
birth rate and magnitude of R0 : for lower levels of R0
or birth rate, low vaccination coverage levels can
maintain the relative burden at<1 even without SIAs
(Fig. S4). Results are not sensitive to the exact pattern
of routine immunization.
Long-term eﬀects of vaccination on CRS burden
Next we estimated the number of CRS cases/1000 live
births after 30 years across possible coverage levels
(Fig. 2, showing only routine immunization). If birth
rates or R0 are low, the burden decreases relative to
the pre-vaccination burden (horizontal lines) for even
small increases in coverage (Fig. 2a). However, for
higher birth rates or R0, cases/1000 live births ﬁrst
increase, representing an increase in average age in-
suﬃciently oﬀset by a decrease in transmission, then
decrease (Fig. 2b, c). The main goal of our analysis
is to identify the minimum level of coverage that
is suﬃcient to avoid an increase in the relative
CRS burden, indicated by an arrow for each curve
(Fig. 2) ; implementing further immunization strat-
egies reduces this necessary coverage level. In all
situations, the minimum coverage level increases
with the time-horizon considered, as the average
age of infection continues to increase gradually
over a sustained routine vaccination programme
(Fig. S5). Eﬀects of even low vaccination coverage
are most beneﬁcial where the birth rate or R0 are
lowest, which correspond to situations where the
burden of CRS is greatest in the absence of vacci-
nation (Fig. 2).
Minimum required levels of coverage
To show eﬀects of varying birth rates and R0
we plotted the minimum required level of coverage
(indicated by the arrow, Fig. 2) as a function of
birth rate for three levels of R0. The minimum
level of coverage increases with birth rate (Fig. 3,
x-axis) and R0 (Fig. 3a–c, respectively), and is re-
duced by implementation of SIAs (Fig. 3, coloured
lines) or vaccination of women of childbearing age
(Fig. 3, gold line). Seasonality had little eﬀect
(Fig. S5).
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Requirements for implementing infant and young
children immunization only
If R0=6, the yearly risk ratio ry remains<1 even for
low vaccination coverage (Fig. S4a), and thus cover-
age levels required to retain total CRS cases below
pre-vaccination levels are low (Fig. 3a). If R0=12,
after an initial ‘honeymoon’ period [34] during
which the risk ratio ry drops (Fig. 1a), for insuﬃcient
coverage, the risk ratio may increase, i.e. more CRS
cases are obtained under the vaccination programme
than in the absence of vaccination; consequently,
for birth rates >20/1000, coverage levels of >80%
(and nearing 100% for birth rates of 30/1000 or
higher) are required (Fig. 3c).
Requirements for implementing measles-like SIAs
Regular SIAs reduce routine coverage needed to see
reductions in CRS relative to the pre-vaccination
burden, since children missed by routine services
may be vaccinated in the SIA (Fig. 2a vs. Fig. 2b ;
Fig. 3, black vs. red lines). However, for high birth
(>35/1000 per year) and reproductive (R0o12) rates,
even with regular SIAs with coverage of 90%, at least
80% routine vaccination coverage is required (and
more if SIA coverage is lower, Fig. S6). Augmenting
routine SIAs with a starting campaign extends the
length of the honeymoon period [34], i.e. the time
after the start of routine infant and young children
vaccination before the susceptible population reaches
Coverage6
0·5
0·8
0·9
5
ρ y
4
3
2
1
0
6
5
ρ y
4
3
2
1
0
5 10 15 20
5 10 15 20
6
5
ρ y
4
3
2
1
0
5 10 15 20
6
5
ρ y
4
3
2
1
0
5 10
Year
15 20
Routine immunization only
Routine + 4 year SIAs
Routine + 4 year SIAs + start campaign 1 - to 4- year-olds
Routine + 4 year SIAs + start campaign 1- to 14-year- olds
(a)
(b)
(c)
(d )
Fig. 1. Dynamics of the relative congenital rubella syndrome (CRS) burden for R0=12, and 40 births/1000 per year for three
diﬀerent levels of routine vaccination coverage (see key) for four diﬀerent immunization strategies (arrows indicate timing of
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the critical size for an epidemic (Fig. 1b–c). A greater
age range in the starting campaign extends the reach
of this eﬀect (Fig. 1c–d), e.g. vaccinating children up
to age 14 years vs. up to age 4 years means that it takes
16 years rather than only 8 years before a new birth
cohort can build-up suﬃciently to cause an outbreak
in older children. Over time, the beneﬁts of the start-
ing vaccination campaign disappear as new suscep-
tibles born after the starting vaccination campaign
enter the at-risk age groups (Fig. 1b, c). Accordingly,
the reduction of the minimum necessary level of vac-
cination to retain the burden below levels obtained in
the absence of vaccination over 30 years is slight (Fig.
3, green vs. red line). Vaccinating women of child-
bearing age reduces the relative burden of CRS and
the minimum level of coverage required in routine
programmes (Fig. 3).
Spatial dynamics in a stochastic environment
The CRS burden per 1000 live births predicted
by a stochastic model that allows for local
extinction/re-introduction is higher than in identically
parameterized deterministic models (Fig. 4b), because
local extinction of rubella leads to susceptible build-up
in older age groups, increasing CRS numbers when
rubella is re-introduced. Reducing imports of infected
individuals, which occurs when a neighbouring
location (city, or country) is vaccinated, can further
substantially increase the total CRS burden (Fig. 4b),
due to a greater time interval between epidemics
(Fig. 4a ; qualitative results are retained over a range
of birth rates). This outcome is variable : in some
simulations, rubella becomes locally extinct, and by
chance, the population never experiences the arrival of
an infected immigrant, so that the total CRS burden
can be lower than that obtained in the absence of vac-
cination of the neighboring location (city or country).
DISCUSSION
Rubella is perhaps the infection for which math-
ematical modelling holds the greatest promise for
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Fig. 2. Eﬀect of routine vaccination coverage levels on congenital rubella syndrome (CRS) burden over 30 years, for diﬀerent
levels of routine infant and young children vaccination coverage only, total number of CRS cases/1000 live births for a
population of 750 000 across diﬀerent birth rates for (a) 12 births/1000, (b) 30 births/1000 and (c) 40 births/1000). Three levels
of R0 are shown (in colour) under weak seasonality in transmission (a=0.2 ; higher seasonality does not alter results).
Horizontal lines indicate the number of CRS cases/1000 live births occurring in the absence of vaccination; points on each
curve above the corresponding line correspond to negative outcomes of vaccination ; arrows indicate the level of coverage
required to avoid this. Note that the exact numbers on the y-axis in any particular context will depend on the precise pattern
of the fertility curve, which may itself vary with birth rate. Here, it is assumed that the pattern over age follows that for Niger.
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improving public health interventions. The epidemi-
ology is straightforward, and thus tractable to model
development, but the eﬀect of vaccination on the
burden of disease is rooted in the nonlinearities of
infectious disease dynamics. These dynamics are
much studied, but here we explore them in a broader
demographic and spatial context than previously.
Across a global spectrum of demographic and epi-
demiological contexts, we show that the nonlinear
epidemic dynamics of rubella can interact in complex
ways with both birth rates and spatial heterogeneity
to inﬂuence the consequences of vaccination.
To be useful, models must be rooted a realistic
public health context, and deciding whether to intro-
duce RCVs into the routine infant immunization
schedule, and what additional vaccination strategies
to use requires consideration of the ﬁnancial and
logistical feasibility of achieving and sustaining
identiﬁed minimum coverage levels in all areas of the
country, and indeed in neighbouring countries.
Although the burden of CRS is small compared to the
overall disease burden in children in certain regions,
the low cost of the rubella vaccine and the ability to
deliver it as a MR combination vaccine mean that it
may be one of the diseases most eﬀectively tackled.
This is particularly true where regular measles SIAs
continue with high campaign coverage. Switching
from the measles vaccine to the MR vaccine entails an
increase in cost – in 2010 the UNICEF discounted
price per dose was US$0.8–1.50 for MMR and
US$0.53 for MR, compared to US$0.22 for measles
(http://www.unicef.org/supply/) – but no additional
resources would be required for distribution: the
combined vaccine would simply be substituted for the
monovalent vaccine. Furthermore, a Global Alliance
for Vaccines and Immunizations (GAVI) support
window for the rubella vaccine is in preparation for
2012 [14].
However, rubella vaccine is also the only common
vaccination whose use has the potential to lead to
a negative outcome, i.e. increased incidence of CRS.
We found that in the simplest analysis, where popu-
lation sizes are large enough that stochastic eﬀects
can be ignored, introduction of routine infant and
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Fig. 3. Minimum level of vaccination required to retain r, the ratio of cumulative congenital rubella syndrome incidence
before and after vaccination<1 over 30 years (y-axis), across births/1000 per year (x-axis) and levels of R0 (panels) for ﬁve
diﬀerent immunization strategies, (i) routine vaccination only, (ii) routine+supplementary immunization activities (SIAs) of
1- to 4-year-olds every 4 years, (iii) routine+SIAs of 1- to 4-year-olds every 4 years+a starting campaign in 1- to 4-year-olds,
(iv) routine+SIAs of 1- to 4-year-olds every 4 years+a starting campaign in 1- to 14-year-olds, and (v) routine+SIAs of 1- to
4-year-olds every 4 years+a starting campaign in 1- to 14-year-olds+vaccination of women of childbearing age (WCB). The
level currently recommended by WHO (80%) is shown (grey line).
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young children rubella vaccination once coverage is
sustainable at o80% is conservative under many
demographic and transmission conditions, particu-
larly when birth rates are <30/1000 (Fig. 3), in line
with previous work [5, 7, 8, 13, 14, 18]. However,
necessary vaccination coverage increases strongly
with birth rate, and this coverage level is insuﬃcient
for routine vaccination alone in countries where the
birth rate is>30/1000 and the basic reproductive rate
of rubella is >8. Starting (‘catch-up’) campaigns
followed by regular high-quality SIAs (Fig. 3) lowers
the requirement for coverage across birth rates, as
long as SIAs reach children who were missed by the
routine programme and in the absence of stochastic
eﬀects (see below). Results are conservative relative to
mixing assumptions (Fig. S5) and robust to the as-
sumption of stable populations (Fig. S7).
Vaccination of women of childbearing age is the
one strategy that will always improve the CRS situ-
ation. While such targeted campaigns should play
an important role in a rubella control strategy, they
face several logistical hurdles. Signiﬁcantly, such a
campaign could not be paired with existing measles
control programmes, and thus would require a
major investment in a vaccination programme aimed
solely at the control of rubella. Additionally, identi-
fying women in need of vaccination may be diﬃcult.
Overall, whether the beneﬁts of pursuing rubella vac-
cination of women of childbearing age outweighs
the costs will depend on coverage and the age proﬁle
of access to vaccination. In our analyses, we set a
gradually increasing pattern of access to vaccination
with age (Fig. S1e), and coverage equivalent to half
that achieved in routine vaccination. This may be
conservative : WHO reports 75% coverage for tetanus
toxoid immunization, a vaccination targeted at preg-
nant women via routine programmes. However, vac-
cination of pregnant women is unlikely to be
implemented for rubella and it is unclear if similar
rates of success could be reached across populations.
The eﬀect of seasonal forcing on CRS burden has
not previously been addressed. Motivated by recent
results highlighting both its amplitude and import-
ance for measles dynamics in a Sahelian context [23],
we explored seasonal forcing in detail here. Our re-
sults suggest that seasonality is rather negligible rela-
tive to eﬀects of birth rate (Fig. S5). Rubella does
frequently display multi-annual cycles [35], which
could aﬀect the age proﬁle of infection [24]. Transient
dynamics interacting with seasonal forcing has been
proposed as the mechanism [11], rather than strong
seasonal forcing per se [10, 36]. Such eﬀects may
only shift the age of infection up by a small amount
[21], and are thereby unlikely to aﬀect the burden of
CRS, but their existence (e.g. [11, 21]) implies that
stochasticity is an important element of the dynamics
of rubella.
If stochasticity is important, the generally positive
situation for vaccination depicted by the determin-
istic analysis here and elsewhere [5, 35] needs to be
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Fig. 4. The eﬀect of reduced infected immigration on the burden of CRS in a stochastic situation. Stochastic simulations
showing bi-weekly rubella incidence in the presence of some immigration of infected individuals [(a) left panel, on average
three infected immigrants per year] or reduced immigration of infected individuals [(a) right panel, on average 0.3 infected
immigrants per year]. Panel (b) shows the numbers of CRS cases/1000 live births [medians (inner horizontal bar), 25% and
75% quantiles (box) and 0.975 and 0.025 quantiles (outer lines) across 10 simulations], and corresponding levels in the
deterministic situation (red asterisks). All simulations had a birth rate of 12/1000 and R0=6 (set since the eﬀect is expected to
be strongest in communities with low transmission and/or birth rate) and population size of 50 000; burdens were assessed
across 40 years.
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interpreted cautiously in a world of heterogeneous
vaccination rates. Local extinction might dominate
rubella dynamics (e.g. see data from Peru [22] and
early data from The Gambia [37]). This will allow
build-up of susceptible individuals in older age groups
(demonstrated for remote areas in Peru [22]) increas-
ing the burden of CRS and potentially altering the
outcomes of vaccination. Our stochastic analysis
highlights that risks are high if vaccination is in-
troduced in one location (country or community) and
there is substantial cross-migration with unvaccinated
communities where rubella circulation is maintained
by imports. These results echo those of Vynnycky
et al. [15] in that inequality in access to private-sector
rubella vaccination when it is not available in the
public sector may aﬀect the CRS burden. Note that
these results will also be sensitive to the assumptions
of the exact generation time of the infection, as well
as the value of the exponent c (since values closer to
1 lead to more violent dynamics more prone to ex-
tinction) and for quantitative predictions these should
be carefully estimated.
Our model makes several assumptions. We as-
sumed that a person’s chance of being vaccinated in
an SIA is independent of their probability of routine
vaccination and vaccination in previous SIAs.
However, those children not covered by routine vac-
cination may have been missed for some reason that
increases their likelihood of being missed by SIAs,
leading to a systematically unvaccinated population.
Recent work has shown that this group may represent
as much as 20% of the population in some countries
[38]. The existence of such a group will cause us to
overestimate the beneﬁt of SIAs; hence we urge cau-
tion in the interpretation of our results and suggest
that the estimated coverage of SIAs be ‘discounted’
and accordingly considered to be up to 20% lower if
such an unreachable population is believed to exist.
This is a key area for future work on speciﬁc contexts.
We assumed that seasonal forcing followed a sinus-
oidal pattern (Fig. S1b). More realistic patterns may
alter the range of multi-annual cycles [10] and could
inﬂuence our conclusions on the weak eﬀect of the
magnitude of seasonal forcing on vaccination out-
comes; time-series data at sub-annual time-scales
would be required to investigate this. Our model is
likely to be robust towards biases from other as-
sumptions; and where biases exist, the model will
tend to be conservative, overestimating rather than
underestimating the minimum required coverage. For
example, we assumed approximately 24 rubella
generations per year; in fact there may be slightly
fewer, since rubella has a generation time of about
18 days [5], implying that our model slightly overesti-
mates yearly transmission rates, thus over-predicting
minimum required levels of vaccination; sensitivity
analyses suggest that this will have little impact over
much of the range of vaccination (Fig. S2), but should
be borne in mind for highest coverage levels. We as-
sumed constant survival rates over age, which will
result in an exponential distribution of the population
over age, and may underestimate the relative pro-
portion of women of childbearing age, and thus the
CRS burden, particularly in populations where birth
rates are lower (e.g. Europe). However, repeating the
analysis with empirically based age trajectories of
survival reﬂecting the likely range of age trajectories
of survival which results in non-stationary popu-
lations (either growing or shrinking, depending on
the balance of mortality and birth rate) does not
much alter required minimum vaccination coverage
(Fig. S7). Finally, we assumed that transmission is
constant over age. If transmission is more clustered
in younger age groups, as has been reported from
surveys of contact patterns over age in European
countries (Fig. S2b) the necessary vaccination cover-
age is higher (Fig. S8), particularly at lower birth and
transmission rates (albeit retaining general patterns
relative to the 80% threshold) ; however, the absolute
number of CRS cases will be much smaller than
is estimated with constant transmission over age
(Fig. S9), as will be the increase driven by insuﬃcient
vaccination. Speciﬁc data needs for improved predic-
tions relative to the various assumptions are detailed
in Supplementary Information S3.
Overall, our results have several implications for
introduction of RCV. First, declining birth rates in
low- and middle-income countries raise the priority
for rubella vaccination because ; (i) falling birth rates
increase the average age at infection, thus increasing
the burden of CRS in the absence of vaccination, and
(ii) the critical vaccination coverage required to re-
duce CRS incidence will be lower at lower birth rates,
increasing the chances of a successful vaccination
programme [36]. Second, given the current global
range of birth rates, in all regions except Africa, if
routine infant and young children measles vaccination
coverage is o80% it is likely to be safe to switch
to MR combined vaccines, in the absence of major
heterogeneities in coverage, particularly as birth
rates fall. Substantial programmatic eﬀorts would be
needed in large countries such as India; however, to
Minimum coverage required for rubella vaccination 2299
avoid potential increases in CRS that could occur
through spatial dynamic eﬀects on transmission if the
substantial heterogeneity in coverage that has been
seen for measles vaccine (with up to fourfold diﬀer-
ences in coverage between states) continued. Third,
private-sector vaccination against rubella should be
monitored as much as possible, to assess whether
private-sector coverage has reached levels suﬃcient
to increase CRS burdens (Fig. 2), and if so, national
introduction policies should be considered. Fourth,
in the African region, where birth rates remain
>40/1000 in many countries and estimates of R0 are
>6 [18], infant and children vaccination alone should
be considered with caution and SIAs would be essen-
tial as long as birth rates remain high. Even with
SIAs, the potential for spikes in CRS incidence to
occur in the short term implies the need for eﬀective
communication to avoid public mistrust of the pro-
gramme. Fifth, the addition of vaccination of women
of childbearing age has the potential to greatly en-
hance programme eﬀectiveness and reduce risks of
increases in CRS. Finally, the potential for local ex-
tinction and delayed outbreaks should be a factor
when considering implementing any of the above re-
commendations. In the WHO African and South-
East Asian regions, the only regions where universal
rubella vaccination is currently uncommon [3], it
would be prudent for changes in rubella vaccine pol-
icy to be taken at regional level rather than by indi-
vidual countries, and for introduction of RCVs to be
accompanied by intensiﬁed eﬀorts to reduce hetero-
geneities in routine vaccination and SIA coverage.
The public health recommendations above are de-
veloped in the context of rubella, but the results of our
analysis also provide a global overview of the degree
to which complex feedback between key drivers in-
herent in infectious disease dynamics shape infection,
and are therefore important to consider for successful
control. Our broad analysis of the eﬀects of season-
ality, spatial coupling, and stochastic eﬀects on both
incidence and the age proﬁle of incidence provide a
global scale overview of the landscape of the dynam-
ics of such infections, key for assessing safe and ef-
fective implementation of control strategies.
CONCLUSIONS
Once immunization against rubella is introduced
there is no going back, so costs and beneﬁts must be
carefully weighed. For low-to-average birth-rate con-
texts, beneﬁts of immunization are likely to be high
across a range of levels of routine coverage, especially
in the presence of additional immunization activities.
For countries with high birth rates, 80% coverage of
routine infant vaccination alone may not remove
all risks of adverse events, and funding will need to
be guaranteed for high-quality SIAs to continue in
addition to routine infant and young children im-
munization. It is also important that policy decisions
be based on not only national levels of coverage, but
also their variability both sub-nationally and across
regions.
NOTE
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
hyg).
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